These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30210621)

  • 1. Loss of UHRF2 Is Associated With Non-small Cell Lung Carcinoma Progression.
    Jin C; Xiong D; Li HR; Jiang JH; Qi JC; Ding JY
    J Cancer; 2018; 9(17):2994-3005. PubMed ID: 30210621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance.
    Peng R; Huang X; Zhang C; Yang X; Xu Y; Bai D
    Onco Targets Ther; 2017; 10():5863-5872. PubMed ID: 29270024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.
    Lu S; Yan D; Wu Z; Jiang T; Chen J; Yuan L; Lin J; Peng Z; Tang H
    Oncol Rep; 2014 Apr; 31(4):1802-10. PubMed ID: 24573556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells.
    Zhang T; Zhao L; Zeng S; Bai L; Chen J; Zhang Z; Wang Y; Duan C
    Int J Mol Med; 2017 Jan; 39(1):126-134. PubMed ID: 28004105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc Finger Protein 618 Regulates the Function of UHRF2 (Ubiquitin-like with PHD and Ring Finger Domains 2) as a Specific 5-Hydroxymethylcytosine Reader.
    Liu Y; Zhang B; Kuang H; Korakavi G; Lu LY; Yu X
    J Biol Chem; 2016 Jun; 291(26):13679-88. PubMed ID: 27129234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity.
    Lu H; Bhoopatiraju S; Wang H; Schmitz NP; Wang X; Freeman MJ; Forster CL; Verneris MR; Linden MA; Hallstrom TC
    Oncotarget; 2016 Nov; 7(46):76047-76061. PubMed ID: 27738314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.
    Cheng F; Qian G; Fang X; Sun J; Chen S; Chen R; Liu S; Li Z; Wu K; Jiang S; Chen Y; Tang N; Chen J; Duan C
    Hepatol Int; 2021 Jun; 15(3):707-719. PubMed ID: 33876395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
    Iguchi T; Ueda M; Masuda T; Nambara S; Kidogami S; Komatsu H; Sato K; Tobo T; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
    Oncology; 2018; 95(3):179-187. PubMed ID: 29909415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of UHRF2 affects malignant phenotypes of HCC and HBV replication by blocking DHX9 ubiquitylation.
    Wu K; Zhang Y; Liu Y; Li Q; Chen Y; Chen J; Duan C
    Cell Death Discov; 2023 Jan; 9(1):27. PubMed ID: 36690646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of m
    Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
    Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
    Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UHRF2 promotes the malignancy of hepatocellular carcinoma by PARP1 mediated autophagy.
    Zhang Y; Wu K; Liu Y; Sun S; Shao Y; Li Q; Sui X; Duan C
    Cell Signal; 2023 Sep; 109():110782. PubMed ID: 37356603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF2, another E3 ubiquitin ligase for p53.
    Bai L; Wang X; Jin F; Yang Y; Qian G; Duan C
    Biochem Biophys Res Commun; 2012 Sep; 425(4):908-11. PubMed ID: 22902639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.
    Lu H; Hallstrom TC
    J Biol Chem; 2013 Aug; 288(33):23833-43. PubMed ID: 23833190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Tang Q; Li M; Chen L; Bi F; Xia H
    Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
    Wang L; Qu J; Zhou L; Liao F; Wang J
    Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis.
    Shi X; Liang W; Yang W; Xia R; Song Y
    Tumour Biol; 2015 May; 36(5):3345-54. PubMed ID: 25524578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
    Liu XH; Lu KH; Wang KM; Sun M; Zhang EB; Yang JS; Yin DD; Liu ZL; Zhou J; Liu ZJ; De W; Wang ZX
    BMC Cancer; 2012 Aug; 12():348. PubMed ID: 22876840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.